Albert Bourla, Pfizer CEO (Markus Schreiber/AP Images)
Years before $43B Pfizer deal, a mystery company made six proposals for Seagen
Before Seagen’s $43 billion deal to be acquired by Pfizer last month, the biotech company had received takeover offers going back to at least 2019 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
